Breast Cancer

Looking for Estrogen Receptor Subtypes Can Maximize Treatment Options

Published in Cancer Weekly, September 12th, 2000

One of the major steps in determining a course of treatment for breast cancer patients is to determine whether or not their tumors are estrogen receptive.

According to a study presented at the British Cancer Research Meeting 2000, breast cancer tumors should be examined even further to determine their estrogen subtypes, so that more specific treatment regimens can be developed.

Scientists at the St. James University Hospital in Great Britain were authors of the study titled "Immunohistochemical Detection of Estrogen Receptor Beta in Paraffin-Embedded Human Breast Tissues."

Researchers analyzed 20 breast biopsy tumors, a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-09-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry